AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2014
Dec 13, 2014
30786_dirs_2014-12-12_ee9ddd77-296a-4084-8619-8c9d22b607ff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2014-12-12
Reporting Person: Magni Giovanni (EVP, Chief Strategy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-12 | Bio-Rad A Common Stock | M | 5000 | $57.49 | Acquired | 16811 | Direct |
| 2014-12-12 | Bio-Rad A Common Stock | S | 5000 | $117.38 | Disposed | 11811 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-12 | Non-Qualified Stock Option (right to buy) | $57.49 | M | 5000 | Disposed | 2015-02-09 | Bio-Rad A Common Stock (5000) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.91 to $117.55, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The option vested in five equal annual installments beginning on February 9, 2006.